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Oxygen consumptiond increased O2 consumption unrelated to active transport by tubular cells and up-
regulated mitochondrial uncoupling protein (UCP)-2 expressions in diabetic kidneys. It is presently unknown
if the increased UCP-2 levels in the diabetic kidney results in mitochondrial uncoupling and increased O2
consumption, which we therefore investigated in this study. The presence of UCP-2 in proximal tubular cells
was conﬁrmed by immunohistochemistry and found to be increased (western blot) in homogenized tissue
and isolated mitochondria from kidney cortex of diabetic rats. Isolated proximal tubular cells had increased
total and ouabain-insensitive O2 consumption compared to controls. Isolated mitochondria from diabetic
animals displayed increased glutamate-stimulated O2 consumption (in the absence of ADP and during
inhibition of the ATP-synthase by oligomycin) compared to controls. Guanosine diphosphate, an UCP
inhibitor, and bovine serum albumin which removes fatty acids that are essential for UCP-2 uncoupling
activity, independently prevented the increased glutamate-stimulated O2 consumption in mitochondria from
diabetic animals. In conclusion, diabetic rats have increased mitochondrial UCP-2 expression in renal
proximal tubular cells, which results in mitochondrial uncoupling and increased O2 consumption. This
mechanism may be protective against diabetes-induced oxidative stress, but will increase O2 usage. The
subsequently reduced O2 availability may contribute to diabetes-induced progressive kidney damage.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionLong-term hyperglycemia is closely associated with an increased
risk to develop chronic renal failure. End-stage renal disease and
cardiovascular complications are the most common causes of death in
diabetic patients, but the mechanisms resulting in diabetic nephro-
pathy is presently unclear.
We have previously reported that diabetic kidneys have reduced
oxygen availability, which at least partly could be linked to increased
oxygen (O2) consumption [1]. The vast majority of O2 consumed in the
kidney (approx. 80%) relates to electrolyte reabsorption and correlates
well with the amount ﬁltered in the glomerulus [2]. Indeed, in the early
stages of the disease, diabetic kidneys often display glomerular
hyperﬁltration with concomitant increase in transport-dependent
oxygen usage [1]. However, we have previously also observed increased
oxygen consumption by tubular cells from diabetic rats with normal
glomerular ﬁltration rates [3], which implies at least one additional
mechanismresponsible for the increasedO2usage in thediabetic kidney.
The mitochondrial O2 usage in the kidney is closely related to the
ADP availability and subsequent ATP production, i.e. coupled to activell Biology, Uppsala University,
l.: +46 18 471 4156; fax: +46 18
l rights reserved.transport [4]. However, mitochondria isolated from brown adipose
tissue display no such relationship between ATP production and O2
usage due to the function of uncoupling protein (UCP)-1. Interestingly,
several different UCP isoforms have been identiﬁed based on their
homology to UCP-1 [5]. Recently, by combining immunohistochem-
istry and PCR techniques we have identiﬁed UCP-2 being expressed in
rat kidneys, especially proximal tubular cells and cells of the
medullary thick ascending loop of Henle [6]. Furthermore, we showed
that UCP-2 protein expression is increased in diabetic kidneys. The
presence of a mitochondrial uncoupling mechanism could potentially
explain the diabetes-induced increase in kidney O2 usage unrelated to
active transport of electrolytes, but it is presently unclear if UCP-2
actually functions as a mitochondrial uncoupler.
In the present study, we tested the hypothesis that mitochondria
from kidneys of hyperglycemic rats have increased uncoupling due to
increased UCP-2 protein expression.
2. Materials and methods
All chemicals were from Sigma-Aldrich (St. Louis, MO, USA) and of highest grade
available if not otherwise stated.
2.1. Animals, diabetes induction and insulin treatment
Inbred male Wistar Furth rats (Scanbur, Sollentuna, Sweden) weighing 250–310 g,
were randomly divided into: age-matched controls, diabetic animals and diabetic
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(R3, Ewos, Södertälje, Sweden). The local animal ethics committee at the University of
Uppsala approved all experiments.
Diabetes was induced by an injection of streptozotocin (45 mg/kg) in the tail vein.
Animals were considered diabetic if blood glucose increased to ≥15 mmol/l within 24 h
and remained elevated. Blood glucose concentrations were determined with test
reagent strips (MediSense, Bedford, MA, USA) from blood samples obtained from the
cut tip of the tail. Insulin treatment (8 IU/kg bw SC; three times per 24 h) started the
same day as diabetes was induced.
2.2. Isolation of renal cells and measurements of in vitro oxygen consumption
The buffer solution had, if not stated otherwise, the following composition in
mmol/l: 113.0 NaCl, 4.0 KCl, 27.2 NaHCO3, 1.0 KH2PO4, 1.2 MgCl2, 1.0 CaCl2, 10.0 HEPES,
0.5 Ca2+-lactate, 2.0 glutamine. The buffer osmolality was adjusted to 298±2 mOsm/kg
H2O as estimated with a freezing-point osmometer (Model 3MO; Advanced Instru-
ments), and the pH was adjusted to 7.40. Streptomycin (VWR International, Stockholm,
Sweden) was added, resulting in a ﬁnal concentration of 50 U/ml. For non-diabetic rats,
the buffer contained 5.8 mmol/l glucose and for diabetic animals the buffer contained
23.2 mmol/l glucose (similar to the blood glucose concentrations in these latter
animals). The renal cells were isolated as previously described [1,7,8]. In brief, the rats
were anesthetized with thiobutabarbital, perfused with phosphate buffered saline
(PBS), the kidneys were excised and the renal capsule was removed. The kidneys were
placed on ice and the cortex and outer medulla were dissected under a stereomicro-
scope. The renal tissue was minced through a metallic mesh-strainer and immediately
placed in an ice-cooled buffer solution (cf. above) containing 0.05% (wt/vol) collagenase.
Thereafter, the minced tissue was incubated at 37 °C, while the buffer was equilibrated
with 95% O2/5% CO2. At least once every 5 min, the buffer-tissue solution was stirred
manually. After incubation, the cell suspension was cooled on ice and ﬁltered through
graded ﬁlters with pore sizes of 180, 75, 53 and 38 µm, respectively. After ﬁltration, the
cells were pelleted using a low centrifugal force (100 G, 4 min) and resuspended in a
collagenase-free buffer. The rinsing procedure was repeated three times to ensure that
no collagenase remained in the ﬁnal cell suspension.
Oxygen consumption was measured as previously described [1,8]. A custom-made
thermostatically controlled (37 °C) gas-tight plexi-glass chamber with a total volume of
1.10 ml was used. The chamber was continuously stirred with an air-driven magnetic
stirrer. A modiﬁed Unisense 500 O2 sensing electrode (Unisense, Aarhus, Denmark),
calibrated with air-equilibrated buffer solution set to 228 µmol/l O2 and Na2S2O5-Fig. 1. Immunohistochemistry directed against UCP-2 in kidneys of normoglycemic control (
cells, but not glomeruli or cells in the distal nephron in both groups is present. However, prox
controls (A+C). Horizontal bars indicate 50 µm.saturated buffer set to zero, was used to measure O2 consumption. After the calibration,
100 µl of cell suspensionwas injected into the chamber and the rate of O2 disappearance
was recorded. At the end of each experiment, a 100 µl sample was taken to determine
the protein concentration using DC Protein Assay (Bio-Rad Laboratories, Hercules, Calif.,
USA). The O2 consumption was calculated as the disappearance rate of O2 adjusted for
protein concentration. In all experimental groups, measurements were conducted on
cells with and without pre-treatment with 1 mmol/l ouabain.
2.3. Mitochondrial isolation and measurements of in vitro oxygen consumption
The rats were decapitated and the kidneys immediately excised and placed in ice-
cold isolation buffer A (in mmol/l: 250 sucrose, 10 HEPES, pH 7.4, 300 mOsm/kg H2O).
Cortex was dissected and homogenized in ice-cold buffer A with 5 complete strokes
with a prechilled Potter–Elvehjem homogenizer (600 rpm). The homogenate was
centrifuged at 600 G (4 °C) for 10min and the supernatant was transferred into two new
tubes and centrifuged at 14,500 G (4 °C) for 5 min. The resulting pellets were
resuspended with buffer A and the last centrifugation step repeated once more. The
ﬁnal pellets were resuspended with buffer B (in mmol/l: 70 sucrose, 220 mannitol, 5
MgCl2, 5 KPO4−, 10 HEPES, pH 7.4, 300 mOsm/kg H2O) with and without 0.3% (wt/vol)
bovine serum albumin (BSA; further puriﬁed fraction V). Samples without BSA was
collected and later used for analysis of UCP-2 protein expression. Oxygen chambers
with a Clark-type electrode (Hansatech Instruments, Kings Lynn, Great Britain),
calibrated with air-equilibrated water to 228 µmol/l O2 and Na2S2O5-saturated water
to zero was used to measure O2 consumption. To a ﬁnal volume of 1.0 ml air-
equilibrated buffer B with or without BSA, mitochondria were added to a ﬁnal
concentration of 0.5 mg/ml and O2 consumption was measured as the rate of O2
disappearance corrected for cytochrome a1 a3 (cytochrome oxidase; Cyt a) content.
Baseline respiration was evaluated before addition of any mitochondrial substrate.
Glutamate-stimulated O2 consumption was achieved by adding glutamate to a ﬁnal
concentration of 10 mmol/l (sodium salt, pH 7.4) and ADP-stimulated O2 consumption
respiration by addition of ADP to a ﬁnal concentration of 300 µmol/l (sodium salt, pH
7.4, containing 0.6 mol MgCl2/mol ADP). The latter was used to assess mitochondria
viability. Mitochondria were incubated with either 12 µg oligomycin/mg protein,
0.5 mmol/l guanosine diphosphate (GDP), 50 µmol/l palmitic acid (PA) or a combination
of oligomycin and GDP or PA. Concentration of substances in the chamber during
measurement was the same as during the incubation of the mitochondria. After each
measurement, a sample from the O2 chamber was frozen for later analysis of Cyt a
concentration.A+C) and hyperglycemic diabetic Wistar Furth rats (B+D). Staining of proximal tubular
imal tubular cells from diabetic rats display a more intense staining (B+D) compared to
Fig. 3. Uncoupling protein (UCP)-2 expressions in mitochondria (normalized to protein)
isolated from kidney cortex of normoglycemic control and diabetic rats. All values are
given as means±SEM.
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Protein concentration was determined by the method of DC Protein Assay (Bio-Rad
Laboratories, Hercules, Calif., USA).
Cyt a content was determined as previously described [9]. Sample was added to 2%
Triton-X-100 (Merck laboratories, Darmstadt, Germany) in 0.1 mol/l PBS (pH 7.4) or
100 µl 2% Triton-X-100 in 0.1 mol/l PBS (pH 7.4) saturated with sodium dithionite. The
oxidized-reduced absorbance spectrum was obtained at 605–630 nm, and the
concentration determined using a millimolar extinction coefﬁcient of 12 with
adjustment for the dilution factor [9].
2.5. Western blot analysis
Samples were homogenized in 700 µl buffer (1.0% NP40, 0.5% sodium deoxycholate,
0.1% SDS, 10 mmol/l NaF, 80 mmol/l Tris, pH 7.5) containing enzyme inhibitors
(Phosphatase inhibitor cocktail-2; 10 µl/ml, and Complete Mini; 1 tablet/1.5 ml; Roche
Diagnostics, Mannheim, Germany). Samples were run on 12.5% Tris–HCl gels with Tris/
glycine/SDS buffer and the proteins were detected, after transfer to nitrocellulose
membranes, using goat anti-rat UCP-2 antibody (1:1000; Santa Cruz Biotechnology,
Santa Cruz, CA) and HRP-conjugated secondary antibody (rabbit anti-goat, 1:10,000;
Kirkegaard and Perry Laboratories, Gaithersburg, MD) by an ECL-camera (Kodak image
station 2000; New Haven, CT). β-actin was detected using mouse anti-rat β-actin
antibody (1:10,000) and secondary HRP-conjugated goat-anti mouse antibody
(1:60,000; Kirkegaard and Perry Laboratories). Western blot analysis of samples from
isolated mitochondria was normalized to protein concentration.
2.6. Immunohistochemistry
For immunohistochemistry, a polyethylene catheter was placed in a carotid artery
and perfused slowly with 20 ml of ice-cold PBS, and the right renal veinwas cut open in
order to facilitate complete perfusion of the kidneys. The right kidney was removed and
ﬁxated in 4% formaldehyde for 72 h and thereafter dehydrated and embedded in
parafﬁn. 5 µm sections were stained as previously described [10]. Sections (5 µm) were
deparafﬁnized and immersed in ethanol with concentration gradients and were then
heated in citrate solution (0.01 mol/l, pH 6.0) for antigen retrieval. Endogenous
peroxidase activity was blocked using 3% H2O2 and non-speciﬁc binding was prevented
by blocking with normal goat serum (Santa Cruz Biotechnology, Heidelberg, Germany).
Thereafter, the sections were incubated with an antibody against UCP-2 in a 1:50
dilution overnight at 4 °C. The sections were rinsed with TBST and incubated with a
biotinylated secondary antibody against goat IgG (Santa Cruz Biotechnology; 1:500).
After rinsing with TBST, the sections were incubated with an avidin biotin enzyme
reagent (ABC Elite Kit; Vector Laboratories, Burlingame, CA, USA). Labeling was
visualized using a peroxide substrate solutionwith 0.8 mmol/l DAB and 0.01% H2O2. The
sections were subsequently counterstained with hematoxylin and mounted.
2.7. Statistics
All values are means±SEM. Multiple comparisons between different groups were
performed using analysis of variance (ANOVA) followed by Fisher's PLSD test. Multiple
comparisons within the same group were performed using repeated measures ANOVA
followed by Dunnett's test for paired comparisons (Statview, Abacus Concepts,
Berkeley, CA, USA). When appropriate, Student's t-test or paired Student's t-test were
used when comparing two data sets. Pb0.05 was considered statistically signiﬁcant.
3. Results
Blood glucose concentrations were 5.2±0.1 mmol/l in the control
animals (n=8) and 20.7±0.6 mmol/l in the two-week diabetic animals
(n=10; Pb0.05).Fig. 2. Uncoupling protein (UCP)-2 expressions normalized to β-actin in homogenized
cortical kidney tissue from normoglycemic control and diabetic rats with and without
intense insulin treatment. All values are given as means±SEM.3.1. UCP-2 protein expression
UCP-2 protein expression was located to proximal tubular cells in
the kidney cortex (Figs. 1A–D) with increased expression in diabetic
kidneys (Figs.1B andD).Western blot analysis of homogenized cortical
tissue (Fig. 2) and isolated mitochondria (Fig. 3) from diabetic rats
showed increased UCP-2 protein expressions compared to controls.
3.2. Cellular oxygen consumption
Proximal tubular cells isolated from diabetic rats displayed
increased transport and ouabain-inhibitable O2 consumption com-
pared to the corresponding controls (Fig. 4).
3.3. Effects of intense insulin treatment
Insulin treatment reduced blood glucose concentrations in diabetic
rats (data not shown) and prevented the increase in UCP-2 protein
expression in the kidney (Fig. 2) and O2 consumption by the isolated
proximal tubular cells (Fig. 4).
3.4. Mitochondrial oxygen consumption
Baseline respiration was similar for both control and diabetic
animals independent of the presence of BSA (Fig. 5). Glutamate
stimulated the O2 consumption only in mitochondria from diabetic
rats (Fig. 5). Oligomycin prevented any ADP stimulation in all groups
(Fig. 5). GDP prevented the glutamate-induced stimulation of O2Fig. 4. Oxygen consumption by isolated proximal tubular cells from normoglycemic
controls and diabetics with and without intense insulin treatment during baseline
(white bars) and ouabain treatment (black bars). All values are given as means±SEM.
⁎ denotes Pb0.05 when compared to baseline within the same group.
Fig. 5. Oxygen consumption by mitochondria isolated from control and diabetic rat kidneys with and without bovine serum albumin (BSA; 0.3% wt/vol) during baseline and after
sequential addition of glutamate (10 mmol/l) and ADP (300 µmol/l). ATP-synthase was inhibited by oligomycin (12 µg/mg protein), uncoupling proteins was inhibited by guanosine
diphosphate (GDP; 0.5 mmol/l) and stimulated by palmitic acid (PA; 50 µmol/l). All values are given as means±SEM. ⁎ denotes Pb0.05 when compared to baseline within the same
group and † denotes Pb0.05 when compared to corresponding treatment within the control group.
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change the response to glutamate in any of the groups (Fig. 5).
Concomitant incubation of mitochondria with BSA abolished all
differences between control and diabetic mitochondria which were
evident when BSA was absent (Fig. 5).
4. Discussion
The main new ﬁnding of the present study is that mitochondria
from diabetic rat kidneys display uncoupling due to increased protein
expression of UCP-2. Glutamate alone stimulated diabetic mitochon-
dria, whereas it had no effect on mitochondria from control kidneys.
The effect of glutamate was totally prevented by GDP, a known
inhibitor of UCP activity. Also, eliminating the fatty acids, by the
addition of BSA to the incubation medium, resulted in a complete lack
of glutamate-stimulated O2 consumption by the diabetic mitochon-
dria, which further strengthens the evidence for mitochondrial
uncoupling since fatty acids are indispensable for upholding the
uncoupling property of UCPs [11–13].
The result from the present study conﬁrms the previous result of
UCP-2 being expressed in proximal tubular cells in kidney cortex [6],
although the commercially available UCP-2 antibody used in the
present study is somewhat unspeciﬁc, i.e. displaying more than one
band on the immunoblot. The immunohistochemistry data presented
in this study should therefore be interpreted with caution and
conﬁrmed by other laboratories using more speciﬁc antibodies before
the intrarenal distribution of UCP-2 is conclusively revealed. However,
increased UCP-2 protein expressions were detected in both homo-
genized cortical tissue and isolated mitochondria from diabetic rat
kidneys compared to normoglycemic controls. The increased UCP-2
expression in the diabetic kidneys correlated to both increased total
and ouabain-insensitive cellular O2 consumption. The diabetes-
induced increase in kidney O2 usage has previously been ascribed to
increased proximal tubular reabsorption [7,14]. An important ﬁnding
of the present study is that intense insulin treatment to the diabetic
rats prevented both the increased UCP-2 protein expression and
concomitant increase in cellular O2 consumption. This ﬁnding links
the stimulation of UCP-2 expression to long-term hyperglycemia and
excludes any nephrotoxic effect of streptozotocin per se.
Ouabain only partly inhibits active transport in rodents since the
Na+/K+-ATPase isoform present in rodents has very low afﬁnity for
ouabain (for review, see [15]). Therefore, only limited information is
attained when analyzing the degree of inhibition of active transport as
a measurement of basal cellular O2 consumption in our experimental
setup. However, the increased ouabain-insensitive O2 consumption by
the diabetic proximal tubular cells warranted further investigations
where mitochondria function is studied in detail.
Fatty acids are pivotal for maintaining the uncoupling activity of
UCPs [11–13]. Mitochondria isolation is usually performed in the
presence of BSA (removes fatty acids) in order to eliminate any
unspeciﬁc mitochondrial uncoupling activity, which might be a
potential problem for especially hepatic mitochondria. The proposed
mechanism of action for of UCP by Skulachev illustrates the crucial
role of fatty acids [16] and our speciﬁc aim of this study was to
investigate the function of UCP-2 and we therefore performed
experiments both in the presence and absence of BSA. As stipulated,
we could only observe uncoupling in the absence of BSA in the
diabetic mitochondria, i.e. when fatty acids are present, which further
strengthen the hypothesis of a diabetes-induced mitochondrial
uncoupling. However, perhaps the most convincing evidence for an
uncoupling of the diabetic mitochondria is the stimulated O2
consumption when the ATP-synthase is inhibited by oligomycin.
Furthermore, the last result in support for a diabetes-induced
mitochondrial uncoupling is that GDP totally prevented the stimula-
tory effect of glutamate onmitochondrial O2 usage. Purine nucleotides
have been shown to be potent inhibitors of UCPs [13,17].As previously reported by Echtay et al, UCPs are activated by PA
[13]. However, in our settings PA did not have any effect, neither with
nor without BSA. These results indicate saturated amounts of fatty
acids in the absence of BSA and that BSA, when present, removes fatty
acids in general together with the added PA. It therefore seems
suitable to include BSA-free experimental groups when studying the
effect of endogenous mitochondrial uncoupling mediated via UCPs.
It has been suggested that a physiological role of UCPs is in the
regulation of mitochondrial production of reactive oxygen species
(ROS) [18]. ROS is generated by the mitochondria during normal
respiration, and recent reports indicate that ROS formation accounts
for 0.1–0.2% of the total normal cellular O2 utilization [19,20].
However, ROS generation is known to increase during various
pathological states, including diabetes and aging [21–23], and
sustained hyperglycemia creates an abnormally high proton gradient
across the inner mitochondrial membrane which results in increased
ROS formation [24–26]. It therefore might be favorable to have a
mechanism to reduce the proton gradient across the mitochondrial
membrane, and this might be the physiological role of UCP-2 in the
diabetic kidney. This speculation is supported by the reports of gene
silencing directed against UCP-2 in murine endothelial cells resulting
in both increased mitochondrial membrane potential and oxidative
stress markers [27]. However, increased mitochondrial uncoupling
will unquestionably result in increased O2 consumption in order to
sustain similar ATP production, which possibly can result in reduced
tissue O2 availability similar to what we have reported for the diabetic
kidney [1,3]. Such a reduced O2 availability may contribute to the
development of diabetes-induced kidney damage, as previously
proposed [28].
In conclusion, sustained hyperglycemia results in mitochondrial
uncoupling due to up-regulation of UCP-2 in isolated mitochondria
from the kidney cortex. Increased uncoupling will contribute to the
increased O2 consumption commonly observed in diabetic kidneys
and potentially mediate the diabetes-induced development of
progressive kidney damage.
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